Médicaments

Imraldi▼ (Adalimumab)

ATC
Médicament orphelin
non

Actualisé il y a 5 mois

Hulio (Adalimumab)

ATC
Médicament orphelin
non

Actualisé il y a 5 mois

Solymbic▼ (Adalimumab)

ATC
Médicament orphelin
non

Actualisé il y a 5 mois

Cyltezo▼ (Adalimumab)

ATC
Médicament orphelin
non

Actualisé il y a 5 mois

Amgevita▼ (Adalimumab)

ATC
Médicament orphelin
non

Actualisé il y a 1 an

Humira (Adalimumab)

ATC
Médicament orphelin
non

Actualisé il y a 1 an

Search all médicaments for Inflammation ou infection de l'œil
 

Zones de formation

Sur epgonline.org, une zone de formation (ZF) est une zone du site dédiée à la formation médicale dans laquelle l'utilisateur peut approfondir, de façon autonome, ses connaissances concernant une maladie ou une procédure médicale/chirurgicale.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Fibrinogen Deficiency in Bleeding

Fibrinogen Deficiency in Bleeding

Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.

En charger d'autres